Lawrence S. Czer, MD

Medical Director, Heart Transplant Program

Associate Medical Director, Mechanical Circulatory Support Program

Co-Medical Director, Cardiothoracic Surgery Database

Professor, Medicine

Advanced Health Sciences Pavilion
127 S. San Vicente Blvd.
Suite A3600
Los Angeles, CA 90048





Lawrence S. Czer, MD

Medical Director, Heart Transplant Program

Associate Medical Director, Mechanical Circulatory Support Program

Co-Medical Director, Cardiothoracic Surgery Database

Professor, Medicine

  • IM/Cardiology

Arrhythmias (Irregular Heartbeat, Heart Rhythm Disorders)

Cardiac Catheterization


Congenital Heart Diseases

Congestive Heart Failure (CHF)

Coronary Artery Disease (CAD)

Endomyocardial Biopsy

Heart Disease

Heart Transplants

Heart Valve Diseases


Intra-Aortic Balloon Pump


Lawrence S. Czer, MD, co-founded the Cedars-Sinai Heart Transplant Program in 1988 with Alfredo Trento, MD. This renowned program is currently the largest in the United States. Excellent clinical skills, innovative practice, and advanced research make Dr. Czer a leading expert in heart transplantation. His research focuses on the mechanisms of cardiac stem (progenitor) cell differentiation and migration in normal and diseased human hearts; molecular, morphological, and functional changes in hearts after transplantation and after insertion of a ventricular assist device; molecular mechanisms of bioprosthetic and native valve calcification; and Cardiothoracic Tissue Repository. Dr. Czer employs molecular, cellular, transgenic and wild-type animal, and human tissue and cells to understand the biology of cardiac stem cells in normal and diseased hearts and to understand mechanisms of cardiac valve calcification. His research has established and maintained a repository of cardiac, vascular, and thoracic tissue for research purposes.

View NIH Biographical Sketch as a PDF

  • Medical School: UCLA, 1977
  • Internship: UCLA, 1978
  • Residency: UCLA, 1980
  • Fellowship: Cedars-Sinai, 1983

View CV as a PDF

  • Board of Advisors, One Legacy, 2017
  • Review Board Member: Thoracic Organ Review Board for UNOS Region 5, 2017

Click here for a list of peer-reviewed publications.

  • Awad M, Czer LS, Esmailian F, Jordan S, De Robertis M, Mirocha J, Patel J, Chang DH, Kittleson M, Ramzy D, et al. Combined Heart and Kidney Transplantation: A 23-Year Experience. Transplant Proc. 2017 Mar;49(2):348-353.
  • Ruan V, Czer LS, Awad M, Kittleson M, Patel J, Arabia F, Esmailian F, Ramzy D, Chung J, DeRobertis M, et al. Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review. Transplant Proc. 2017 Mar;49(2):253-259.
  • Awad M, Czer LS, Hou M, Golshani SS, Goltche M, De Robertis M, Kittleson M, Patel J, Azarbal B, Kransdorf E, et al. Early Denervation and Later Reinnervation of the Heart Following Cardiac Transplantation: A Review. J Am Heart Assoc. 2016 Nov 1;5(11).
  • Kransdorf EP, Fishbein MC, Czer LS, Patel JK, Velleca A, Tazelaar HD, Roy RR, Steidley DE, Kobashigawa JA, Luthringer DJ. Pathology of Chronic Chagas Cardiomyopathy in the United States:  A Detailed Review of 13 Cardiectomy Cases. Am J Clin Pathol. 2016 Aug;146(2):191-8. [Epub 2016 Jul 17].
  • Kansara P, Czer L, Awad M, Arabia F, Mirocha J, De Robertis M, Moriguchi J, Ramzy D, Kass RM, et al. Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc. 2014 Jan-Feb;46(1):249-255.
  • Kransdorf EP, Czer LS, Luthringer DJ, Patel JK, Montgomery SP, Velleca A, Mirocha J, Zakowski PC, Zabner R, et al. Heart transplantation for Chagas cardiomyopathy in the United States. Am J Transplant. 2013 Dec;13(12):3262-3268.
  • Czer LS, Phan A, Ruzza A, Rafiei M, Setareh-Shenas S, Caceres M, Awad M, Soliman C, Mirocha J, et al. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation. Transplant Proc. 2013 Jul-Aug;45(6):2393-2398.
  • Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012 Mar 10;379(9819):895-904.

Show moreShow less


Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Lawrence S. Czer, MD